Sep 22 | Mar 22 | Sep 21 | Mar 21 | |
---|---|---|---|---|
Income Statement | - | |||
Total Revenue | - | - | - | - |
Gross Profit | - | - | - | - |
EBIT | - | - | - | - |
EBITDA | - | - | - | - |
Net Income Common Stockholders | - | - | - | - |
Balance Sheet | - | |||
Cash, Cash Equivalents and Short-Term Investments | $ 9.82B | $ 2.32B | $ 5.39B | $ 4.10B |
Total Assets | $ 10.22B | $ 7.56B | $ 5.65B | $ 4.30B |
Total Debt | $ 173.80M | $ 95.70M | $ 98.40M | $ 98.70M |
Net Debt | $ -9.65B | $ -2.22B | $ -5.29B | $ -4.00B |
Total Liabilities | $ 9.77B | $ 7.16B | $ 5.31B | $ 4.02B |
Stockholders Equity | $ 457.40M | $ 409.20M | $ 338.60M | $ 285.30M |
Cash Flow | - | |||
Free Cash Flow | - | - | - | - |
Operating Cash Flow | - | - | - | - |
Investing Cash Flow | - | - | - | - |
Financing Cash Flow | - | - | - | - |